ConductScience.org, home

Gene · 57721

NIH grants1,078

NIH grants whose papers are about the gene, through NIH's grant-paper links.

301 to 320 of 1,078

Download this page as JSON
GrantTitleMETTL14 papersNewest fiscal year
ZICAG000616Analysis of complex biological systems by high-throughput genomic technologies12025
ZICES102445Gene Expression and Microarrays12025
R01CA243386Targeting FTO to treat acute myeloid leukemia162024
R35NS097370Functional roles of genetic risk factors for brain disorders in neurogenesis and neurodevelopment92024
T32CA062948Cancer Pharmacology62024
R01AR077615Epigenetic enhancer control in maintaining homeostasis and preventing carcinogenesis in the epidermis32024
R61AI169659Targeting HIV-1 RNA modifications in latently infected CD4+ T cells for therapeutic development32024
K99DK135927Interrogating the role of m6A mRNA methylation in the aging of the β-cell and diabetes22024
P30ES030283University of Louisville Center for Integrative Environmental Health Sciences22024
R01AI151162Roles of m6A mRNA Methylation in Innate Immunity22024
R01AI151215Cap specific N6 methylation of viral mRNA by the cellular methyltransferase PCIF122024
R01CA238662Targeting the Circadian Rhythm in Glioblastoma Stem Cells (R01CA238662)22024
R01CA239128Synthetic lethality based combination approaches to ARID1A mutation in ovarian cancer22024
R01CA239227FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers22024
R01CA251150Characterization and modeling of m6A RNA methylation in cancer22024
R01DK101989Uncovering the role for MSI2 network in hematopoietic stem cells22024
R01ES031522Oxidative stress and RNA methylation22024
R01GM136922Mechanisms Underlying Enhancer Rnp Mediated Gene Regulation And Genome Organization22024
R01HG011868High-throughput detection of transcriptomic and epitranscriptomic variation and kinetics using MarathonRT22024
R01HL149766Licensing LncRNAs in Atherosclerosis22024

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/57721/grants?page=16